Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase Transcript
Greetings, and welcome to the Tonix Pharmaceuticals Planet MicroCap webcast. It is now my pleasure to introduce your host, CEO, Seth Lederman. Thank you, Mr. Lederman, you may begin.
Thank you very much for the introduction and thank everyone who's participating in watching the webcast and sending in Q&A for your interest in Tonix and our story. I'm Seth Lederman CEO of Tonix and I'll give you an update on our story today.
This is our standard safe harbor disclosure, and we will be making forward-looking statements. We are a publicly listed company and I refer you to our 10-K for more complete information about the company.
These are our two lead programs on slide 3. The first, with a lot of interest already in the Q&A room, is our vaccine to protect against COVID-19. This is in the pre-clinical stage of development. It's a live virus vaccine, and it's designed on our horsepox vaccine platform to express the CoV-2 to spike protein. And
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |